The randomized controlled trial
暂无分享,去创建一个
[1] J. Sloan,et al. Decision making during serious illness: what role do patients really want to play? , 1992, Journal of clinical epidemiology.
[2] D G Altman,et al. Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals. , 1994, JAMA.
[3] D. Moher,et al. The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration , 2001, Annals of Internal Medicine.
[4] M. Ardagh. Futility has no utility in resuscitation medicine , 2000, Journal of medical ethics.
[5] D. Zingmond,et al. Regional and institutional variation in the initiation of early do-not-resuscitate orders. , 2005, Archives of internal medicine.
[6] E. Bruera,et al. Impact of physician sitting versus standing during inpatient oncology consultations: patients' preference and perception of compassion and duration. A randomized controlled trial. , 2005, Journal of pain and symptom management.
[7] W. Haley,et al. Current research findings on end-of-life decision making among racially or ethnically diverse groups. , 2005, The Gerontologist.
[8] L. Heffner,et al. Production of prolactin by smooth muscle cells cultured from human uterine fibroid tumors. , 1993, The Journal of clinical endocrinology and metabolism.
[9] Douglas G Altman,et al. How to randomise , 1999, BMJ.
[10] M K Campbell,et al. Extending the CONSORT statement to cluster randomized trials: for discussion. , 2001, Statistics in medicine.
[11] D. Elbourne,et al. Zelen randomization: attitudes of parents participating in a neonatal clinical trial. , 1998, Controlled clinical trials.
[12] P. Muskin,et al. Effects of religiosity on patients' perceptions of do-not-resuscitate status. , 2004, Psychosomatics.
[13] B. Messinger-Rapport,et al. Predictors of do not resuscitate orders in the nursing home. , 2005, Journal of the American Medical Directors Association.
[14] J. Grizzle. THE TWO-PERIOD CHANGE-OVER DESIGN AN ITS USE IN CLINICAL TRIALS. , 1965, Biometrics.
[15] D. Moher,et al. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials , 2001, The Lancet.
[16] N. Chabbert-Buffet,et al. Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications. , 2005, Human reproduction update.
[17] P. Butow,et al. Misunderstanding in cancer patients: why shoot the messenger? , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.
[18] E. Bruera,et al. Patient preferences versus physician perceptions of treatment decisions in cancer care. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] K. Wallston,et al. The Development of a Brief Version of the Santa Clara Strength of Religious Faith Questionnaire , 2002 .
[20] J. Curtis. Communicating with patients and their families about advance care planning and end-of-life care. , 2000, Respiratory care.
[21] K. Coyne,et al. The UFS‐QOL, a New Disease‐Specific Symptom and Health‐Related Quality of Life Questionnaire for Leiomyomata , 2002, Obstetrics and gynecology.
[22] Sylvie Chevret,et al. Risk of post-traumatic stress symptoms in family members of intensive care unit patients. , 2005, American journal of respiratory and critical care medicine.
[23] Kenneth F. Schulz,et al. The CONSORT Statement , 1996 .
[24] M. Merino,et al. A single mid-follicular dose of CDB-2914, a new antiprogestin, inhibits folliculogenesis and endometrial differentiation in normally cycling women. , 2000, Human reproduction.
[25] D. Elbourne,et al. Making sense of randomization; responses of parents of critically ill babies to random allocation of treatment in a clinical trial. , 1997, Social science & medicine.
[26] P. Maguire,et al. The relationship between patients' concerns and psychological distress in a hospice setting , 1998, Psycho-oncology.
[27] W. Baile,et al. Discussing disease progression and end-of-life decisions. , 1999, Oncology.
[28] J. Steinauer,et al. Systematic Review of Mifepristone for the Treatment of Uterine Leiomyomata , 2004, Obstetrics and gynecology.
[29] R. J. Hayes,et al. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. , 1995, JAMA.
[30] M. Kenward,et al. Design and Analysis of Cross-Over Trials , 1989 .
[31] S. Assmann,et al. Subgroup analysis and other (mis)uses of baseline data in clinical trials , 2000, The Lancet.
[32] Duncan Macrae,et al. UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation , 1996, The Lancet.
[33] J. Ptacek,et al. Breaking Bad News: A Review of the Literature , 1996 .
[34] A. Patel,et al. The frequency of uterine leiomyomas. , 1990, American journal of clinical pathology.
[35] J. Reel,et al. In vitro antiprogestational/antiglucocorticoid activity and progestin and glucocorticoid receptor binding of the putative metabolites and synthetic derivatives of CDB-2914, CDB-4124, and mifepristone , 2004, The Journal of Steroid Biochemistry and Molecular Biology.
[36] A. Sherman,et al. Measuring religious faith in cancer patients: reliability and construct validity of the Santa Clara strength of religious faith questionnaire , 2001, Psycho-oncology.
[37] A. Lethaby,et al. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids. , 2000, The Cochrane database of systematic reviews.
[38] S. Pocock,et al. Clinical Trials: A Practical Approach , 1984 .
[39] K. Schulz,et al. Subverting randomization in controlled trials. , 1995, JAMA.
[40] R. Williams,et al. Effects of GnRH analogues, 'add-back' steroid therapy, antiestrogen and antiprogestins on leiomyoma and myometrial smooth muscle cell growth and transforming growth factor-beta expression. , 2002, Molecular human reproduction.
[41] M. Somerfield,et al. Can 40 seconds of compassion reduce patient anxiety? , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[42] D. Elbourne,et al. Reactions of participants to the results of a randomised controlled trial: exploratory study , 1998, BMJ.
[43] U. Haag. Technologies for Automating Randomized Treatment Assignment in Clinical Trials , 1998 .
[44] Douglas G. Altman,et al. RANDOMISATION : ESSENTIAL FOR REDUCING BIAS , 1991 .
[45] E. Bruera,et al. Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study. , 2000, Archives of internal medicine.
[46] R. Kruse,et al. Effect of Do‐Not‐Resuscitate Orders on Hospitalization of Nursing Home Residents Evaluated for Lower Respiratory Infections , 2004, Journal of the American Geriatrics Society.
[47] Stephen Senn,et al. Cross-over trials in clinical research , 1993 .
[48] D. Dixon,et al. Etiology and pathogenesis of uterine leiomyomas: a review. , 2003, Environmental health perspectives.
[49] Philip H. Ramsey. Nonparametric Statistical Methods , 1974, Technometrics.
[50] A. Fairchild,et al. In pursuit of an artful death: discussion of resuscitation status on an inpatient radiation oncology service , 2005, Supportive Care in Cancer.
[51] C. McPherson,et al. Effective methods of giving information in cancer: a systematic literature review of randomized controlled trials. , 2001, Journal of public health medicine.
[52] V T Chang,et al. Validation of the Edmonton Symptom Assessment Scale , 2000, Cancer.
[53] R. Labianca,et al. Edmonton symptom assessment scale: Italian validation in two palliative care settings , 2005, Supportive Care in Cancer.
[54] C. Steiner,et al. Hysterectomy Rates in the United States 1990–1997 , 2002, Obstetrics and gynecology.
[55] A. Donner,et al. Design and Analysis of Cluster Randomized Trials , 2001 .
[56] G. Enas,et al. Baseline Comparability in Clinical Trials: Prevention of “Poststudy Anxiety” , 1990 .
[57] Neeraj Arora,et al. Patient preferences for medical decision making: who really wants to participate? , 2000, Medical care.
[58] L. Nieman,et al. Luteal phase dose-response relationships of the antiprogestin CDB-2914 in normally cycling women. , 2003, Human reproduction.
[59] E. Bruera,et al. The Edmonton staging system for cancer pain: preliminary report , 1989, Pain.